The production volumes of chemical and pharmaceutical products in Germany have experienced significant fluctuations over the past decade. The series stood at approximately 197.02 billion Euros in value in 2023.
From 2013 to 2018, the industry saw consistent year-on-year positive growth, with rates ranging from 0.66% to 3.5%. However, there was a notable dip in 2019 (-2.64%) and a sharp decline in 2020 (-15.4%), likely influenced by external economic factors such as the global pandemic. In 2021, the industry rebounded strongly with a 33.64% increase, although the recovery was not sustained in 2022 with an 8.35% downturn. The year 2023 showed a slight growth of 0.79%, indicating a more stable trajectory.
Over the last five years, the average annual growth rate (CAGR) was 0.33%, reflecting modest overall growth. For the 2024 to 2028 forecast period, a more optimistic trend is expected, with a projected 5-year CAGR of 0.61%, culminating in a growth rate of 3.08% by 2028.
In the coming years, watch for trends such as increased investment in sustainable chemical production, advancements in biotechnology, and the impact of regulatory changes on the pharmaceutical industry. Focus should also be on the industry's adaptation to global supply chain disruptions and potential shifts towards digital transformation and automation.
